[HTML][HTML] Insights into the tumor microenvironment—components, functions and therapeutics

K Baghy, A Ladányi, A Reszegi, I Kovalszky - International Journal of …, 2023 - mdpi.com
Similarly to our healthy organs, the tumor tissue also constitutes an ecosystem. This implies
that stromal cells acquire an altered phenotype in tandem with tumor cells, thereby …

[HTML][HTML] Prospects and challenges of CAR-T cell therapy combined with ICIs

Y Lv, X Luo, Z **e, J Qiu, J Yang, Y Deng… - Frontiers in …, 2024 - frontiersin.org
Immune checkpoint molecules are a group of molecules expressed on the surface of
immune cells that primarily regulate their immune homeostasis. Chimeric antigen receptor …

Immunomodulatory precision: A narrative review exploring the critical role of immune checkpoint inhibitors in cancer treatment

J Qiu, Z Cheng, Z Jiang, L Gan, Z Zhang… - International Journal of …, 2024 - mdpi.com
An immune checkpoint is a signaling pathway that regulates the recognition of antigens by T-
cell receptors (TCRs) during an immune response. These checkpoints play a pivotal role in …

Hallmarks of cancer resistance

M Tufail, JJ Hu, J Liang, CY He, WD Wan, YQ Huang… - Iscience, 2024 - cell.com
This review explores the hallmarks of cancer resistance, including drug efflux mediated by
ATP-binding cassette (ABC) transporters, metabolic reprogramming characterized by the …

Phenylboronic acid-functionalized biomaterials for improved cancer immunotherapy via sialic acid targeting

AK Jangid, K Kim - Advances in Colloid and Interface Science, 2024 - Elsevier
Phenylboronic acid (PBA) is recognized as one of the most promising cancer cell binding
modules attributed to its potential to form reversible and dynamic boronic ester covalent …

Association of thrombocytopenia with immune checkpoint inhibitors: a large-scale pharmacovigilance analysis based on the data from FDA adverse event reporting …

G Liu, S Zhang, Z Mo, T Huang, Q Yu, X Lu… - Frontiers in …, 2024 - frontiersin.org
Introduction: An increasing number of immune-related adverse events (irAEs) induced by
immune checkpoint inhibitors (ICIs) have been reported during clinical treatment. We aimed …

Advancing personalized medicine in brain cancer: Exploring the role of mRNA vaccines

F Lin, EZ Lin, M Anekoji, TE Ichim, J Hu… - Journal of Translational …, 2023 - Springer
Advancing personalized medicine in brain cancer relies on innovative strategies, with
mRNA vaccines emerging as a promising avenue. While the initial use of mRNA vaccines …

[HTML][HTML] Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms

GJ Joseph, DB Johnson, RW Johnson - Journal of Bone Oncology, 2023 - Elsevier
Immune checkpoint inhibitors (ICIs) have revolutionized the field of anti-cancer therapy over
the last decade; they provide durable clinical responses against tumors by inhibiting …

Cardiovascular toxicity of immune therapies for cancer

NL Palaskas, HJ Ali, E Koutroumpakis, S Ganatra… - bmj, 2024 - bmj.com
In addition to conventional chemoradiation and targeted cancer therapy, the use of immune
based therapies, specifically immune checkpoint inhibitors (ICIs) and chimeric antigen …

Lamivudine, doravirine, and cabotegravir downregulate the expression of human endogenous retroviruses (HERVs), inhibit cell growth, and reduce invasive capability …

V Zanrè, F Bellinato, A Cardile, C Passarini… - International Journal of …, 2024 - mdpi.com
This study explores the impact of antiretroviral administration on the expression of human
endogenous retroviruses (HERVs), cell growth, and invasive capability of human melanoma …